Ping An Biomedical Aktie
Bilanz/GuV
| Fiskaljahr (Ende: September) | 2020/2021 | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|---|
| EBITDA in Mio. | ||||||
| EBITDA in Mio. | 10 CN¥ | 12 CN¥ | 1 CN¥ | 0 CN¥ | -15 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | - | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | - | - | - |
| Operatives Ergebnis (EBIT) in Mio. | ||||||
| Operatives Ergebnis (EBIT) in Mio. | 8 CN¥ | 11 CN¥ | 1 CN¥ | 0 CN¥ | -15 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | - | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | - | - | - |
| Finanzergebnis in Mio. | ||||||
| Finanzergebnis in Mio. | 6 CN¥ | 3 CN¥ | 4 CN¥ | 5 CN¥ | 49 CN¥ | - |
| Ergebnis vor Steuern (EBT) in Mio. | ||||||
| Ergebnis vor Steuern (EBT) in Mio. | 8 CN¥ | 10 CN¥ | 0 CN¥ | -1 CN¥ | -15 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | - | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | - | - | - |
| Steuern auf Einkommen und Ertrag in Mio. | ||||||
| Steuern auf Einkommen und Ertrag in Mio. | 3 CN¥ | 2 CN¥ | 1 CN¥ | 1 CN¥ | -2 CN¥ | - |
| Ergebnis nach Steuer in Mio. | ||||||
| Ergebnis nach Steuer in Mio. | 5 CN¥ | 7 CN¥ | -1 CN¥ | -1 CN¥ | -13 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | - | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | - | - | - |
| Nettogewinn/-verlust in Mio. | ||||||
| Nettogewinn/-verlust in Mio. | - | - | - | - | - | - |
Aktiva
| Fiskaljahr (Ende: September) | 2020/2021 | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|---|
| Umlaufvermögen in Mio. | ||||||
| Umlaufvermögen in Mio. | 70 CN¥ | 79 CN¥ | 77 CN¥ | 53 CN¥ | 64 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | 76 CN¥ | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | 53 CN¥ | 64 CN¥ | - |
| Anlagevermögen in Mio. | ||||||
| Anlagevermögen in Mio. | 3 CN¥ | 3 CN¥ | 3 CN¥ | 4 CN¥ | 5 CN¥ | - |
| Aktiva in Mio. | ||||||
| Aktiva in Mio. | 74 CN¥ | 82 CN¥ | 80 CN¥ | 57 CN¥ | 68 CN¥ | - |
Passiva
| Fiskaljahr (Ende: September) | 2020/2021 | 2021/2022 | 2022/2023 | 2023/2024 | 2024/2025 | 2025/2026 |
|---|---|---|---|---|---|---|
| kurzfristiges Fremdkapital in Mio. | ||||||
| kurzfristiges Fremdkapital in Mio. | 76 CN¥ | 77 CN¥ | 86 CN¥ | 64 CN¥ | 23 CN¥ | - |
| langfristiges Fremdkapital in Mio. | ||||||
| langfristiges Fremdkapital in Mio. | 0 CN¥ | 0 CN¥ | 0 CN¥ | 0 CN¥ | 0 CN¥ | - |
| Fremdkapital in Mio. | ||||||
| Fremdkapital in Mio. | 76 CN¥ | 77 CN¥ | 86 CN¥ | 64 CN¥ | 23 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | 85 CN¥ | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | 64 CN¥ | 23 CN¥ | - |
| Minderheitenanteil in Mio. | ||||||
| Minderheitenanteil in Mio. | 0 CN¥ | 0 CN¥ | 0 CN¥ | 0 CN¥ | 0 CN¥ | - |
| Eigenkapital in Mio. | ||||||
| Eigenkapital in Mio. | -2 CN¥ | 5 CN¥ | -6 CN¥ | -7 CN¥ | 45 CN¥ | - |
| 1. Quartal | ||||||
| 1. Quartal | - | - | - | - | - | - |
| 2. Quartal | ||||||
| 2. Quartal | - | - | - | -6 CN¥ | - | - |
| 3. Quartal | ||||||
| 3. Quartal | - | - | - | - | - | - |
| 4. Quartal | ||||||
| 4. Quartal | - | - | - | -7 CN¥ | 45 CN¥ | - |
| Passiva in Mio. | ||||||
| Passiva in Mio. | 74 CN¥ | 82 CN¥ | 80 CN¥ | 57 CN¥ | 68 CN¥ | - |
Quelle: Leeway